Browse investments

Invest in Foghorn Therapeutics on Stash

Foghorn Therapeutics Inc. is focused on the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system.

To buy fractional shares of Foghorn Therapeutics stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Ticker: FHTX

Foghorn Therapeutics

$5.40

-6.57%

(1W)

$

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years. Historical performance data are provided “as is” and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by Thomson Reuters (Refinitiv). ©2024 Thomson Reuters. Stash cannot and does not represent or guarantee that any of the information available via Refinitiv is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

FHTX Performance Breakdown

Share Price

$5.40

Today's change

4.85%

Year to date change (YTD)

17.65%

Dividend yield

0.0

Last dividend paid

N/A

Last dividend pay date

N/A

About FHTX

Foghorn Therapeutics Inc. is focused on the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system. The Company's Gene Traffic Control platform allows it to identify, validate and potentially drug targets within the chromatin regulatory system. It is initially focused in oncology. It is developing FHD-286, a selective, allosteric ATPase inhibitor and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors. FHD-286 is allosteric and orally available, small-molecule, enzymatic inhibitor of BRG1 and BRM, that is initially being developed for the treatment of acute myeloid leukemia (AML) and uveal melanoma. FHD-609 is an intravenous, small molecule protein degrader of BRD9. The Company is also engaged in developing additional programs targeting large populations that include selective BRM and selective ARID1B modulators.

Foghorn Therapeutics Stock Ticker

FHTX

For more information

https://foghorntx.com/

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years. Historical performance data are provided “as is” and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by Thomson Reuters (Refinitiv). ©2024 Thomson Reuters. Stash cannot and does not represent or guarantee that any of the information available via Refinitiv is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

Invest in Foghorn Therapeutics on Stash

Foghorn Therapeutics Inc. is focused on the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system.

To buy fractional shares of Foghorn Therapeutics stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Certain companies are volatile

Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.

Foghorn Therapeutics stock news

24/7 Wall Street

Is Invesco's China Technology ETF Still A Buy After Trouncing The S&P 500 With 35% Run?

China tech stocks spent much of 2024 and early 2025 under regulatory anxiety, trade tensions, and economic slowdown fears.

about 6 hours ago

CNBC

Stellantis resurrects $100,000 Ram TRX V-8 pickup truck amid industry deregulation

Stellantis is resurrecting a gas-powered Ram pickup truck with a V-8 engine called the TRX as it faces fewer federal emissions regulations. The 2027 Ram 1500 SRT TRX will be available in late 2026 for around $100,000.

about 8 hours ago

Business Insider

Elon Musk gave nearly $100 million worth of Tesla shares to charity for 'tax planning'

Elon Musk gave away nearly $100 million worth of Tesla shares to undisclosed charities on Tuesday. An SEC filing said the gift was made in connection with "year-end tax planning.

about 11 hours ago

24/7 Wall Street

Will Simplify Managed Futures ETF Finally Move Higher In 2026?

Simplify Managed Futures Strategy ETF ( NYSEARCA:CTA ) has disappointed investors seeking diversification through trend-following strategies.

about 7 hours ago

Why invest with Stash?

Fractional shares

Thousands of stocks and ETFs. No investing minimums.

Unlimited trades

Plus no add-on trading commission fees.^†

Diversification analysis

Custom investment recommendations can help you diversify.

Automatic investing

Dividend reinvestment,⁸ recurring investments, and more.

The Stock-Back® Card

We’ll give you matching stock in companies you shop at.¹

Learn how to invest

Get professional advice and education at every step.

How to buy Foghorn Therapeutics stock on Stash

Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Foghorn Therapeutics’s share price is determined by its bid-ask spread, which is the difference between the price that buyers are willing to pay and the price that sellers are willing to accept. Foghorn Therapeutics’s price can fluctuate throughout the course of each trading day—when you buy Foghorn Therapeutics through Stash, we execute the market order during our next available trading window (we have two a day). At Stash, we don’t recommend trying to predict the market when buying investments. We believe it can be a better strategy to buy quality investments you believe in, then hang onto them.

Use our historic performance chart to see real-time Foghorn Therapeutics stock price and the Foghorn Therapeutics news feed to help further your research before investing in fractional shares with any dollar amount you choose.

Stash offers two subscription plans: Stash Growth and Stash+.

Each plan can help you reach different goals and offers a unique combination of financial accounts and features. All plans include access to a personal brokerage account—also known as your personal investment account. You can use your Stash personal portfolio to purchase any of the available investments on our platform, as well as access our suite of automatic saving and investing tools. Learn more about Stash pricing.

Once your market order of Foghorn Therapeutics stock is complete, you'll officially be a shareholder of Foghorn Therapeutics!